BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.80
-0.55 (-1.81%)
Jun 18, 2026, 1:02 PM CST
Market Cap763.24M -8.3%
Revenue (ttm)262.66M -10.2%
Net Income42.43M -3.6%
EPS1.65 -4.0%
Shares Out 25.61M
PE Ratio18.06
Forward PEn/a
Dividend1.50 (5.03%)
Ex-Dividend DateAug 7, 2025
Volume6,110
Open30.00
Previous Close30.35
Day's Range29.55 - 30.00
52-Week Range28.00 - 35.80
Beta0.18
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory animals in Taiwan and internationally. The company offers lab animals, such as rat, mice, and others, as well as surgical services; and rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment. It also offers reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin tes... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 91
Stock Exchange Taipei Exchange
Ticker Symbol 6662
Full Company Profile

Financial Performance

In 2025, BioLASCO Taiwan's revenue was 262.66 million, a decrease of -10.20% compared to the previous year's 292.50 million. Earnings were 42.43 million, a decrease of -3.63%.

Financial Statements